Výsledky vyhledávání - "G A, Alshafie"

Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesis

Autor: H, Abou-Issa, R W, Curley, G A, Alshafie, K L, Weiss, M, Clagett-Dame, J S, Chapman, S M, Mershon

Publikováno v: Anticancer research. 21(6A)

The antitumor effects of N-(4-hydroxyphenyl)retinamide (4-HPR), and its stable C-linked analog, 4-hydroxybenzylretinone (4-HBR) on the regression of established 7,12-dimethylbenz(a)anthracene(DMBA)-induced rat mammary tumors were compared. 4-HBR is a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d56c831ed817081bf42398590353e160
https://pubmed.ncbi.nlm.nih.gov/11911255

Zobrazit plný text záznamu

Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis

Autor: H M, Abou-Issa, G A, Alshafie, K, Seibert, A T, Koki, J L, Masferrer, R E, Harris

Publikováno v: Anticancer research. 21(5)

Recent chemopreventive studies in our laboratories showed that the COX-2 inhibitor, celecoxib, inhibited the induction of mammary cancer by 7,12-dimethylbenz(a)anthracene (DMBA). In this study, we examined the relative chemopreventive effect of varyi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::334db6aaf24ff0edd0cafb0c8a600b91
https://pubmed.ncbi.nlm.nih.gov/11848504

Zobrazit plný text záznamu

Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor

Autor: R E, Harris, G A, Alshafie, H, Abou-Issa, K, Seibert

Publikováno v: Cancer research. 60(8)

Nonsteroidal anti-inflammatory drugs (NSAIDs) have been observed to reduce the relative risk of breast cancer. This prompted our investigation of the chemopreventive potential of celecoxib, a specific cyclooxygenase 2 blocker, against mammary carcino

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b78d21c3337b5716270c1cce1add48ce
https://pubmed.ncbi.nlm.nih.gov/10786667

Zobrazit plný text záznamu

Chemopreventive activity of a C-glucuronide analog of N-(4-hydroxyphenyl) retinamide-O-glucuronide against mammary tumor development and growth

Autor: H M, Abou-Issa, G A, Alshafie, R W, Curley, M F, Wong, M, Clagett-Dame, J J, Repa, V, Sikri

Publikováno v: Anticancer research. 19(2A)

The long term chemopreventive effects of the N-(4-hydroxyphenyl) retinamide-O-glucuronide (4-HPROG), and its stable C-linked benzyl glucuronide analog, retinamidobenzyl glucuronide (4-HPRCG) on the growth and development of 7,12-dimethylbenz[a]anthra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cea502223149c6a75e15dba16deef2ce
https://pubmed.ncbi.nlm.nih.gov/10368645

Zobrazit plný text záznamu

Chemotherapeutic evaluation of N-(4-hydroxyphenyl) retinamide-O-glucuronide in the rat mammary tumor model

Autor: H, Abou-Issa, R W, Curley, M J, Panigot, S N, Tanagho, B S, Sidhu, G A, Alshafie

Publikováno v: Anticancer research. 17(5A)

The growth inhibitory effects of N-(4- Hydroxyphenyl) retinamide (4-HPR) and its glucuronide derivative, N-(4-Hydroxyphenyl) retinamide-O-glucuronide (4-HPROG) on established DMBA induced rat mammary tumors were compared. The results indicate that th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d6edf50152287146a04f21834bbcf1c9
https://pubmed.ncbi.nlm.nih.gov/9413168

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání